| Date | Title | Description | Source |
| 05.03.2024 | Gain Therapeutics Presents Data at the AD/PD™ 2024 Conferenc... | - | globenewsw... |
| 03.05.2023 | Gain Therapeutics Awarded CHF 2.5 million Innosuisse Grant t... | - | globenewsw... |
| 28.04.2023 | Swiss Accelerator: Innosuisse supports 53 companies with CHF... | | startuptic... |
| 02.03.2022 | Alliance for Artificial Intelligence in Healthcare Elects Ne... | “AI will continue to have a demonstrable impact on human health. Having spent the last three years i... | prweb.com/... |
| 08.02.2022 | Gain Therapeutics Presents Preclinical Data on its Structura... | BETHESDA, Md., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a ... | marketscre... |
| 18.01.2022 | Gain Therapeutics Announces R&D Day Event and Participat... | - Neuroscience and Beyond: Harnessing Computational Technology and Allosteric Modulators to Drug the... | marketscre... |
| 29.12.2021 | Gain Therapeutics : Reports Inducement Grants Under Nasdaq L... | Gain Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BETHESDA, MD, Decem... | marketscre... |
| 29.12.2021 | Gain Therapeutics Reports Inducement Grants Under Nasdaq Lis... | BETHESDA, Md., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or ... | marketscre... |
| 12.11.2021 | Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial... | Gain Therapeutics, Inc.
Reports Third Quarter 2021 Financial Results and Business Update
Data from P... | marketscre... |
| 12.11.2021 | Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial... | Data from Patient-Derived iPSC Study Evaluating STAR Compounds Show Positive Effects on Disease Onse... | marketscre... |
| 04.11.2021 | Gain Therapeutics to Present at the 12th Annual Jefferies Lo... | In-Person Dates: November 16th-17th
Virtual Dates: November 18th-19th
BETHESDA, Md., Nov. 04, 2021 (... | marketscre... |
| 26.10.2021 | Gain Therapeutics, Inc. Announces Appointment of Five Member... | BETHESDA, Md., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or ... | marketscre... |
| 20.10.2021 | Gain Therapeutics : Appoints Matthias Alder as Chief Operati... | Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer
BETHESDA, MD, October 19, 2021 ... | marketscre... |
| 08.09.2021 | Press Release : Gain Therapeutics, Inc. Announces Positive T... | GT-02287and GT-02329 compounds display positive effects on GCase activity
and related parameters
---... | marketscre... |
| 08.09.2021 | Gain Therapeutics : Announces Positive Topline Data in Patie... | GT-02287and GT-02329 compounds display positive effects on GCase activity and related parameters
---... | marketscre... |
| 02.09.2021 | Gain Therapeutics : to Present at the H.C. Wainwright 23rd A... | BETHESDA, Md., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or... | marketscre... |
| 27.05.2021 | GAIN THERAPEUTICS, INC.
Gain Therapeutics to Present at the... | BETHESDA, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a b... | marketscre... |
| 17.05.2021 | GAIN THERAPEUTICS, INC.
Gain Therapeutics : to Participate ... | BETHESDA, Md., May 17, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a b... | marketscre... |
| 27.04.2021 | GAIN THERAPEUTICS, INC.
Gain Therapeutics to Present at the... | BETHESDA, Md., April 27, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) a ... | marketscre... |
| 19.03.2021 | Gain Therapeutics raised $46 million through Nasdaq listing | | startuptic... |
| 19.03.2021 | Gain Therapeutics raised $46 million through Nasdaq listing | Gain Therapeutics offers 3,636,364 shares of its common stock at a price of $11.00 per share. The sh... | startuptic... |
| 22.07.2020 | Gain Therapeutics secures $10 million | Gain Therapeutics is a biotechnology company focused on developing first-in-class medicines that tar... | startuptic... |
| 22.07.2020 | Gain Therapeutics secures $10 million | | startuptic... |
| 21.07.2020 | Gain Therapeutics, Inc. Announces Close of $10 Million Serie... | Eric I Richman appointed CEO and Director | 3bfuturehe... |
| 21.07.2020 | Gain Therapeutics, Inc. Announces Close of $10 Million Serie... | Financing intended to accelerate IND-enabling studies of allosteric drug candidates for rare
genetic... | marketscre... |
| 26.07.2019 | EUR 1.4m grant for Gain Therapeutics | | startuptic... |
| 01.04.2019 | Swiss Biotech Day to shed light on 13 emerging startups | | startuptic... |
| 13.03.2019 | Two foundations join forces to fund Gain Therapeutics’ appro... | | startuptic... |
| 20.02.2019 | Ticino-based Gain Therapeutics raises €2.5 million in Series... | | startuptic... |
| 19.02.2019 | Gain Therapeutics Closes €2.5M Series A Financing | GT Gain Therapeutics SA, a Lugano, Switzerland-based preclinical stage biotech company, closed a €2.... | finsmes.co... |
| 19.02.2019 | Helsinn Investment Fund Invests €1 Million in Gain Therape... | Luxembourg, 19 February 2019: Helsinn Investment Fund S.A, SICAR, a fund focused on early-stage inve... | 3bfuturehe... |
| 20.02.2018 | Gain Therapeutics spins off to develop treatments for rare m... | | startuptic... |
